NCT03445637View on ClinicalTrials.gov

Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

RecruitingOBSERVATIONAL

Enrollment

540

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

July 5, 2025

Study Completion Date

July 5, 2025

Conditions

Breast Neoplasm

Trial Locations (1)

Unknown

RECRUITING

Pfizer Tower, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY